{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T10:15:50Z","timestamp":1770545750349,"version":"3.49.0"},"reference-count":26,"publisher":"The Japanese Society for Medical Mycology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3314\/mmj.20-00011","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T22:10:35Z","timestamp":1606687835000},"page":"55-60","source":"Crossref","is-referenced-by-count":4,"title":["Development of an Animal Model of Onychomycosis in Guinea Pigs"],"prefix":"10.3314","volume":"61","author":[{"given":"Nami","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Department of Surgical Pathology, Toho University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Toho University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lipner SR, Scher RK: Onychomycosis: Clinical overview and diagnosis. J Am Acad Dermatol 80: 835-851, 2019.","DOI":"10.1016\/j.jaad.2018.03.062"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Belyayeva E, Gregoriou S, Chalikias J, Kontochristopoulos G, Koumantaki E, Makris M, Koti I, Katoulis A, Katsambas A, Rigopoulos D: The impact of nail disorders on quality of life. Eur J Dermatol 23: 366-371, 2013.","DOI":"10.1684\/ejd.2013.2048"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zaias N: Onychomycosis. Arch Dermatol 105: 263-274, 1972.","DOI":"10.1001\/archderm.105.2.263"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hay RJ, Baran R: Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol 65: 1219-1227, 2011.","DOI":"10.1016\/j.jaad.2010.09.730"},{"key":"5","unstructured":"5) Gupta AK, Ryder JE, Lynch LE, Tavakkol A: The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence. J Drugs Dermatol 4: 302-308, 2005."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Jain S, Sehgal VN: Itraconazole: an effective oral antifungal for onychomycosis. Int J Dermatol 40: 1-5, 2001.","DOI":"10.1046\/j.1365-4362.2001.01039.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Poulakos M, Grace Y, Machin JD, Dorval E: Efinaconazole and Tavaborole. J Pharm Pract 30: 245-255, 2017.","DOI":"10.1177\/0897190016630904"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Watanabe S, Kishida H, Okubo A: Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study. J Dermatol 44: 753-759, 2017.","DOI":"10.1111\/1346-8138.13816"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tatsumi Y, Yokoo M, Senda H, Kakehi K: Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine. Antimicrob Agents Chemother 46: 3797-3801, 2002.","DOI":"10.1128\/AAC.46.12.3797-3801.2002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shimamura T, Kubota N, Nagasaka S, Suzuki T, Mukai H, Shibuya K: Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents. Antimicrob Agents Chemother 55: 3150-3155, 2011.","DOI":"10.1128\/AAC.00399-11"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Itoyama T, Uchida K, Yamaguchi H, Fujita S: Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs. J Antimicrob Chemother 40: 441-444, 1997.","DOI":"10.1093\/jac\/40.3.441"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Shimamura T, Kubota N, Shibuya K: Animal model of dermatophytosis. J Biomed Biotechnol 2012: 125384, 2012.","DOI":"10.1155\/2012\/125384"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Goss WA, Actor P, Jambor WP, Pagano JF: The <i>Trichophyton mentagrophytes<\/i> and <i>Microsporum canis<\/i> infection of the guinea-pig. J Invest Dermatol 40: 299-304, 1963.","DOI":"10.1038\/jid.1963.153"},{"key":"14","unstructured":"14) Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S: The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials. J Drugs Dermatol 13: 815-820, 2014."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Elewski BE, Aly R, Baldwin SL, Gonz&aacute;lez Soto RF, Rich P, Weisfeld M, Wiltz H, Zane LT, Pollak R: Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies. J Am Acad Dermatol 73: 62-69, 2015.","DOI":"10.1016\/j.jaad.2015.04.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Elewski BE: Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev 11: 415-429, 1998.","DOI":"10.1128\/CMR.11.3.415"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Daniel CR 3rd, Norton LA, Scher RK: The spectrum of nail disease in patients with human immunodeficiency virus infection. J Am Acad Dermatol 27: 93-97, 1992.","DOI":"10.1016\/0190-9622(92)70163-A"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kaplan MH, Sadick N, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S: Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 16: 485-506, 1987.","DOI":"10.1016\/S0190-9622(87)70066-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Olnes MJ, Kotliarov Y, Biancotto A, Cheung F, Chen J, Shi R, Zhou H, Wang E, Tsang JS, Nussenblatt R, Consortium CHI: Effects of systemically administered hydrocortisone on the human immunome. Sci Rep 6: 23002, 2016.","DOI":"10.1038\/srep25215"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Asz-Sigall D, Tosti A, Arenas R: Tinea unguium: diagnosis and treatment in practice. Mycopathologia 182: 95-100, 2017.","DOI":"10.1007\/s11046-016-0078-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kreijkamp-Kaspers S, Hawke K, Guo L, Kerin G, Bell-Syer SE, Magin P, Bell-Syer SV, van Driel ML: Oral antifungal medication for toenail onychomycosis. Cochrane Database Syst Rev 7: CD010031, 2017.","DOI":"10.1002\/14651858.CD010031.pub2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Fleming TE, Brodell RT: Subungual abscess: a bacterial infection of the nail bed. J Am Acad Dermatol 37: 486-487, 1997.","DOI":"10.1016\/S0190-9622(97)70153-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Claman HN: Corticosteroids and lymphoid cells. N Engl J Med 287: 388-397, 1972.","DOI":"10.1056\/NEJM197208242870806"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Long DA, Shewell J: A species difference with regard to the effect of cortisone acetate on body weight, gamma-globulin and circulating antitoxin levels. J Hyg (Lond) 54: 452-460, 1956.","DOI":"10.1017\/S0022172400044739"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lipner SR: Pharmacotherapy for onychomycosis: new and emerging treatments. Expert Opin Pharmacother 20: 725-735, 2019.","DOI":"10.1080\/14656566.2019.1571039"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sugiura K, Sugimoto N, Hosaka S, Katafuchi-Nagashima M, Arakawa Y, Tatsumi Y, Jo Siu W, Pillai R: The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment. Antimicrob Agents Chemother 58: 3837-3842, 2014.","DOI":"10.1128\/AAC.00111-14"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/61\/4\/61_20-00011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T03:15:41Z","timestamp":1607138141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/61\/4\/61_20-00011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.20-00011","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}